Skip to main content
Download PDF

Association between elevated serum transaminase and moderately increased albuminuria: a cross-sectional study in western Tokushima, Japan

BMC Nephrology volume 24, Article number: 358 (2023) Cite this article

Abstract

Background

This study aimed to identify the factors relating to moderately increased albuminuria among middle-aged and older individuals in Japan.

Methods

We conducted specific health examinations in which we measured albuminuria levels, and administered a questionnaire survey to record participants’ lifestyles in western Tokushima Prefecture, Japan. A total of 1,660 people whose albuminuria was less than 300 mg/g creatinine (Cr) were analyzed. We divided participants into two groups—those with normal albuminuria (< 30 mg/gCr) and those with moderately increased albuminuria (≥ 30 mg/gCr, > 300 mg/gCr)—and compared their characteristics. To investigate all relevant factors, we conducted a multivariate logistic regression analysis.

Results

The moderately increased albuminuria group were significantly older and had, among them, significantly higher percentages of a body mass index (BMI) ≥ 25 kg/m2, diabetes, hypertension, and mild liver disorder (aspartate transaminase ≥ 31 U/L or alanine aminotransferase ≥ 31 U/L or gamma-glutamyl transferase ≥ 51 U/L). (p < 0.01) In a multivariate logistic regression analysis that used microalbuminuria as an independent variable, we found the adjusted odds ratio (AOR) and 95% confidence interval (CI) to be significantly higher among individuals with diabetes (AOR: 2.04, 95% CI: 1.40–2.99); hypertension (AOR: 1.90, 95% CI: 1.36–2.65); BMI ≥ 25 kg/m2 (AOR: 1.76, 95% CI: 1.27–2.44); and mild liver disorder (AOR: 1.54, 95% CI: 1.10–2.18).

Conclusions

In addition to diabetes, hypertension, and BMI ≥ 25 kg/m2, this study found that among the middle-aged and older general population living in western Tokushima Prefecture, there were cases of mild liver disorder (elevated serum transaminase), which independently associated with moderately increased albuminuria. Therefore, in health checkups targeting the general population, there is a need to consider measuring albuminuria, even in those who have only mild liver dysfunction (health guidance level).

Trial registration

N/A.

Peer Review reports

Background

Patients with chronic kidney disease (CKD) mainly present with reduced glomerular filtration rates (GFR; < 60 mg/g creatinine [Cr)) and/or symptoms of albuminuria [1]. Those whose CKD has progressed to end-stage renal disease undergo renal dialysis and/or receive renal transplantation [2]. Previous studies showed CKD was associated with cardiovascular disease [3], stroke [4], severe anemia [5], and other diseases, as well as a rise in mortality rates [6]. The number of CKD patients worldwide is growing, and the World Health Organization predicts that the CKD mortality rate per 100,000 people will increase from 12.2 in 2012 to 14 in 2030 [7]. In Japan, the number of CKD patients is estimated, to be approximately 13.3 million, or one out of roughly eight people aged 20 and older [8]. CKD is one of the most serious public health problems globally.

Moderately increased albuminuria refers to more than 30 mg/gCr, but less than 300 mg/gCr [9]. We know that diabetic nephropathy can be detected early in patients with diabetes by measuring microalbuminuria levels [10]. Therefore, regular tests for urinary albumin in diabetes patients are available in Japan and covered by public medical insurance. A previous population-based cohort study reported that moderately increased albuminuria is a predictor of death caused by cardiovascular disease [11]. Urinary albumin levels are considered an indicator of vascular endothelial damage, including renal glomerular and cardiovascular damage.

Therefore, if urinary albumin tests are conducted in health checkups for the general population and appropriate measures are taken for those with moderately increased albuminuria, such as visits to nephrologists and health guidance for lifestyle modification, atherosclerotic diseases, including end-stage renal disease and cardiovascular disease, may be prevented. However, health checkups for individuals in Japan generally do not include albuminuria tests.

Previous epidemiological patient-based or hospital-based studies involving patients with diabetes have reported that moderately increased albuminuria is a predictor of end-stage renal disease and decreasing estimated GFR (eGFR) [12]. These studies have also reported that moderately increased albuminuria is associated with high blood pressure [13, 14] and elevated body mass index (BMI) [14, 15]. However, few population-based epidemiological studies have reported on moderately increased albuminuria and its other associated factors. In the general population, moderately increased albuminuria has been reported to be associated with high fasting blood sugar [13], high blood pressure [13] and elevated BMI [15]. Especially, to our knowledge, there exist no population-based epidemiological studies that have reported an association between moderately increased albuminuria and elevated serum transaminase. If the association between moderately increased albuminuria and elevated serum transaminase is clarified in the general population, atherosclerotic diseases and may be prevented more effectively in health checkups.

Therefore, this study aimed to identify various associated factors including moderately increased albuminuria and elevated serum transaminase. In western Tokushima Prefecture, Japan, we measured the albuminuria levels of the residents recruited for this study who were receiving health checkups.

Methods

Study participants

The study participants were residents of the cities of Mima and Miyoshi and the towns of Tsurugi and Higashi-Miyoshi, in western Tokushima Prefecture. They underwent regular specific health checkups at various health care centers. These specific health checkups are offered each year to individuals aged 40–74 to prevent or improve metabolic syndrome.

In preparation for the study, the authors provided an explanatory leaflet to these health care centers, as well as verbal explanations regarding the survey to individuals undergoing specific health checkups. In addition to undergoing various clinical tests and answering the questions that form part of the specific health checkups, those who had agreed to participate in the survey had their urinary albumin measured.

In total, 1,693 people took part in the survey from June 2021 to January 2022. There were no participants with missing data, and a total of 1,660 participants—after excluding those with macroalbuminuria—were analyzed. The characteristics of the analyzed participants are shown in Table 1.

Table 1 Characteristics of the analyzed participants (N = 1,660)
Full size table

To protect the participants’ personal information, we eliminated their names and dates of birth from all their data. This study was conducted in accordance with the Declaration of Helsinki and the national ethical guidelines. Informed consent was obtained from each participant. This study protocol was approved by the Ethics Committee of Tokushima University Hospital (approval number: 3944).

Measurements

Clinical tests performed during specific health checkups included the following: height (m), weight (kg), systolic and diastolic blood pressure (mmHg), fasting blood glucose (tested after fasting for at least ten hours; mg/dl), HbA1c (%), LDL cholesterol (mg/dl), HDL cholesterol (mg/dl), triglycerides (mg/dl), serum aspartate aminotransferase (AST; U/l), serum alanine aminotransferase (ALT; U/l), and serum gamma-glutamyl transferase (GGT; U/l).

The questionnaire provided during the specific health checkups included the following items: smoking and drinking habits, medication history (antihypertensive drugs, diabetes drugs, dyslipidemia drugs), and tendency to partake in habitual exercise.

BMI was calculated using the formula BMI (kg/m2) = Weight (kg)/ Height (m)× Height (m), and any values exceeding 25 kg/m2 were seen as indicating obesity. BMI of less than 25 kg/m2 was considered not obesity.

Regarding smoking, the answer was set as two options, “Yes” or “No,” to the question, “Are you currently a habitual smoker?” (Previous habitual smokers who had refrained from smoking for the past month or more were instructed to answer “No”). Participants who answered “Yes” were placed in the category of “Currently smoking: Yes.” Regarding drinking, three options (“Every day,” “Occasionally,” and “Sometimes”) were set as the answers to the question: “How often do you drink alcohol beverages per week?” For the question asking about the drinking quantity—“How much alcohol beverages do you drink per day?”—four options were set (“1 drink/day,” “1–2 drinks/day,” “2–3 drinks/day,” and “3 or more drinks/day”). One drink is equivalent to approximately 20 g of ethanol consumption. Regarding “Currently drinking,” participants who met both criteria, in other words “drinking every day” and “drinking quantity exceeding 1 drinks/day,” were placed in the category of “Moderate drinking: No.”

Two options, “Yes” and “No”, were set for the question pertaining habitual exercise habits: “Have you been engaging in a sweat-inducing workouts lasting more than 30 minutes per session, more than twice per week for more than a year?” Participants who answered “Yes” were placed in the category of “Habitual exercise: Yes.”

Hypertension was defined as follows: systolic blood pressure ≥ 140 mmHg, diastolic blood pressure ≥ 90 mmHg, or currently taking antihypertensive medications [11]. In all other cases, it was assumed to be normal. Diabetes was defined as HbA1c ≥ 6.5%, fasting blood glucose ≥ 126 mg/dl, or currently taking antihyperglycemic medications or insulin injections [12]. In all other cases, it was assumed to be normal and borderline. Dyslipidemia was defined as LDL cholesterol ≥ 140 mg/dl, HDL cholesterol < 40 mg/dl, Triglycerides ≥ 150 mg/dl, or currently taking dyslipidemia medication [11]. In all other cases, it was assumed to be normal. Mild liver disorder was defined as follows, based on standard specific health checkups and the health guidance program formulated by the Japanese Health Ministry in 2018: AST ≥ 31 IU/L, ALT ≥ 31 IU/L, or GGT ≥ 51 IU/L [16]. In Japan, this is the level of liver damage which signals the need for health intervention and so on. In all other cases, it was assumed to be normal.

Albuminuria, according to a midstream spot urine test, was measured using immune nephelometry. Based on the Japanese Society of Nephrology’s guidelines, we divided albuminuria into three categories: normoalbuminuria (< 30 mg/gCr), moderately increased albuminuria (≥ 30 mg/gCr and < 300 mg/gCr) (formerly called albuminuria), and macroalbuminuria (≥ 300 mg/gCr) [17].

Statistical analysis

First, the participants’ background characteristics were compared between the normoalbuminuric group and the moderately increased albuminuria group. Continuous variables were shown using the median and standard deviation, while categorical variables were shown using proportion (%). To confirm the differences between the two groups, the Student’s t-test and the chi-squared test were used.

Second, to calculate the adjusted odds ratio (AOR) and 95% confidence intervals (CIs) for the moderately increased albuminuria with elevated serum transaminase, the multivariate logistic regression model was applied. The model was adjusted for mild liver disorder as well as for sex, age, BMI, currently smoking, moderate drinking, habitual exercise, diabetes, and hypertension. Previous population-based epidemiological studies found an association between moderately increased albuminuria and diabetes, hypertension and obesity. (Model 1)

Third, to calculate the AOR and 95% CIs for the association of moderately increased albuminuria with the combination of elevated AST or low AST/ALT ratio, and elevated GGT, the multivariate logistic regression model was applied. In Model 2, a combination of elevated AST and elevated GGT was added in place of the mild liver disorder of Model 1. In Model 3, a combination of low AST/ALT ratio and elevated GGT was added in place of the mild liver disorder of Model 1.

Statistical tests were based on two-side probabilities, and a p value of less than 0.05 was considered significant. All statistical analyses were performed using IBM SPSS Statistics version 28.0 for Windows.

Results

Table 2 shows the differences between the normoalbuminuric group and the moderately increased albuminuria group. Compared with the normoalbuminuric group, the moderately increased albuminuria group were, in general, significantly older, and had a significantly higher percentage of participants with BMI ≥ 25 kg/m2, diabetes, hypertension, dyslipidemia, and mild liver disorder (AST ≥ 31 U/L or ALT ≥ 31 U/L or GGT ≥ 51 U/L). (p < 0.001)

Table 2 Characteristics of normoalbuminuric and moderately increased albuminuria groups
Full size table

Table 3 shows the results of the multivariate logistic regression analysis regarding associations with moderately increased albuminuria. (Model 1) The AOR for moderately increased albuminuria was significantly higher among patients with mild liver disorder (AST ≥ 31 U/L or ALT ≥ 31 U/L or GGT ≥ 51 U/L; AOR: 1.54, 95% CI: 1.10–2.18). Other AORs for moderately increased albuminuria were diabetes (AOR: 2.04, 95% CI: 1.40–2.99), hypertension (AOR: 1.90, 95% CI: 1.36–2.65), and BMI ≥ 25 kg/m2 (AOR: 1.76, 95% CI: 1.27–2.44).

Table 3 Multivariate logistic regression analysis regarding associations on moderately increased albuminuria
Full size table

Table 4 shows the results of the multivariate logistic regression analysis regarding associations of moderately increased albuminuria combined with elevated ALT or low AST/ALT ratio and elevated GGT. In Model 2, compared with those with ALT < 31IUL and GGT < 31IU/L, there was a non-significant increase in AOR in the other groups. In Model 3, compared with those with ALT < 31IUL and GGT < 31IU/L, there was a significant increase in AOR in those with AST/ALT < 1 and GGT < 51IU/L (AOR: 1.52, 95% CI: 1.02–2.27).

Table 4 Association of combination of AST or AST/ALT ratio, and GGT with moderately increased albuminuria
Full size table

Discussion

The results of our population-based cross-sectional study shows an association between moderately increased albuminuria and diabetes, hypertension, obesity and mild liver dysfunction (health guidance level), independently. Mild liver disorder (health guidance level) is seen as being present when one or more of the following are met: AST ≥ 31 U/L or ALT ≥ 31 U/L or GGT ≥ 51 U/L. Mild liver disorder refers to participants who show normal-high serum transaminase. In this study, the percentage of mild liver disorder was 23.0%, while that of the general population was rather high. To our knowledge, few population-based studies have shown that moderately increased albuminuria is independently associated with obesity/liver disorder. More specifically, our study is the first to illustrate the association between moderately increased albuminuria and mild liver disorder (health guidance level) independently. Our results suggest that, in health checkups geared toward the general population, testing albuminuria be considered, even in those who have only mild liver disorder (health guidance level).

Previous epidemiological studies showed that proteinuria, or CKD including proteinuria (≥ (1+), dipstick analysis), not moderately increased albuminuria, or decreasing eGFR is associated with elevated serum GGT or ALT. Ishigami et al. addressed the independent association between proteinuria and elevated serum GGT in their population-based cross-sectional study [18]. Moreover, Shen et al. reported that elevated serum GGT was a predictor of the incidence of CKD in their population-based cohort study [19]. Further of note here is the work from Ochiai et al., who—following their study, which included middle-aged women who had an annual health checkup—stated that elevated serum ALT was associated with CKD, regardless of GGT elevation [20].

In recent years, population-based studies have reported an association between non-alcoholic fatty liver disease (NAFLD) and CKD [21, 22]. Indeed, an epidemiological study focused on prediabetic and non-diabetic hospitalized patients revealed that NAFLD, but not mild liver disorder, was independently associated with moderately increased albuminuria [23]. However, to our knowledge, in a population-based study, moderately increased albuminuria has not been associated with mild liver disorder such as elevated serum GGT, ALT, and AST. From earlier stages of metabolic syndrome, mild renal abnormalities may be associated with mild liver disorder.

A large-scale Japanese cross-sectional study showed the lowest probability of proteinuria in mild drinkers. [18] The same study suggested that GGT had a clinically greater impact on proteinuria than alcohol consumption [18]. This study found no significant association between moderately drinking and moderately increased albuminuria. However, the association with elevated GGT was similar. Future studies should conduct a survey that includes the amount and frequency of different types of alcoholic beverages and drinking patterns.

Given the mechanism of association between liver disorder and renal diseases such as moderately increased albuminuria, decreasing eGFR and so on, we are assuming increased oxidative stress and insulin resistance. Oxidative stress is known to cause proteinuria [24] and lead to increase serum GGT levels [25]. Serum GGT levels have a potential use as a marker of oxidative stress. Moreover, serum GGT is reported to be associated with insulin resistance [26], while insulin resistance is known to be associated with renal abnormalities such as CKD, for example [27]. More specifically, an epidemiological study among non-obese and non-diabetic inpatients showed that moderately increased albuminuria was independently associated with insulin resistance [28].

Elevated serum ALT was found to be independently associated with CKD among middle-aged women, regardless of the GGT elevation [20]. A cross-sectional study in a rural Chinese population revealed a positive association between elevated serum ALT levels and cardiometabolic risk factors, such as hypertension and abdominal obesity [29]. Elevated serum ALT may be caused by damaged liver cells and the accumulation of fat in the liver. However, the mechanism of association between elevated serum ALT and renal disease remains unclear.

The present study showed that low AST/ALT ratio was significantly associated with moderately increased albuminuria even in the absence of elevated GGT. However, there was no significant association between elevated ALT and increased albuminuria. (Table 4) Further studies are needed to clarify the association between the combination of elevated AST or low AST/ALT ratio, elevated GGT, and moderately increased albuminuria.

This study has several limitations that must be acknowledged. First, we were not able to determine the causal relationship between moderately increased albuminuria and liver disorder (health guidance level) because our study was cross-sectional in nature. Second, the data on smoking, drinking, exercise, and so on were based on reports compiled by the respondents themselves, so recall bias may exist; participants tended to deny that they smoked, so there was a risk of under-reporting. Indeed, a study which targeted the middle-aged and elderly population showed smoking to be independently associated with moderately increased albuminuria [30]. In the above-mentioned survey, smokers and non-smokers were identified based on the concentrations of urinary cotinine. Third, as the present study included participants who had already taken part in regular group health checkups, there was a risk that a selection-bias may have existed. There was also a likelihood that the sample included a large number of highly health-conscious people. People who regularly visit clinics may have received their health-checkups there. Indeed, in general, health checkup rates were not very high. In Japan, the national participation rate for specific health checkups was 53.1% in FY2021 [31]. Fourth, there is a possibility that confounding factors existed, other than those which were adjusted in the present study. As we conducted no oral glucose tolerance tests, borderline diabetes was not included as a covariate. High normal blood pressure, which was similarly not included as a covariate, is also reported to be associated with moderately increased albuminuria [13].

Conclusions

This study recruited middle-aged and older general residents as participants and showed that an independent association exists between elevated serum transaminase and moderately increased albuminuria. As such, in health checkups targeting the general population, there is a need to consider measuring albuminuria, even in individuals who have only mild liver disorder (health guidance level).

Data Availability

The datasets analyzed during the current study are available from the corresponding author on reasonable request, and have been approved by the Ethics Committee of Tokushima University Hospital.

Abbreviations

CKD:

chronic kidney disease

GFR:

glomerular filtration rates

Cr:

creatinine

eGFR:

estimated GFR

BMI:

body mass index

AST:

aspartate transaminase

ALT:

alanine transaminase

GGT:

gamma-glutamyl transferase

AOR:

adjusted odds ratio

CI:

confidence interval

NAFLD:

non-alcoholic fatty liver disease

References

  1. National Kidney Foundation. In: KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. In: Part 4. Definition and classification of stages and classification of stages of chronic kidney disease. 2002. https://www.kidney.org/sites/default/files/docs/ckd_evaluation_classification_stratification.pdf. Accessed 29 Nov 2023.

  2. Hallan SI, Matsushita K, Sang Y, Mahmoodi BK, Black C, Ishani A, et al. Age and association of kidney measures with mortality and end-stage renal Disease. JAMA. 2012;308(22):2349–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Perkovic V, Verdon C, Ninomiya T, Barzi F, Cass A, Patel A, et al. The relationship between proteinuria and coronary risk: a systematic review and meta-analysis. PLoS Med. 2008;5(10):e207.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Masson P, Webster AC, Hong M, Turner R, Lindley RI, Craig JC. Chronic Kidney Disease and the risk of Stroke: a systematic review and meta-analysis. Nephrol Dial Transplant. 2015;30(7):1162–69.

    Article  CAS  PubMed  Google Scholar 

  5. Lefebvre P, Vekeman F, Sarokhan B, Enny C, Provenzano R, Cremieux PY. Relationship between hemoglobin level and quality of life in anemic patients with chronic Kidney Disease receiving epoetin alfa. Curr Med Res Opin. 2006;22(10):1929–37.

    Article  CAS  PubMed  Google Scholar 

  6. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073–81.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Consultation WE. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–63.

    Article  Google Scholar 

  8. Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, Hara S, et al. Prevalence of chronic Kidney Disease in the Japanese general population. Clin Exp Nephrol. 2009;13(6):621–30.

    Article  PubMed  Google Scholar 

  9. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80(1):17–28.

  10. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset Diabetes. N Engl J Med. 1984;310(6):356–60.

    Article  CAS  PubMed  Google Scholar 

  11. Konno S, Munakata M. Moderately increased albuminuria is an Independent risk factor of cardiovascular events in the general Japanese population under 75 years of age: the Watari study. PLoS ONE. 2015;10(4):e0123893.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Koye DN, Magliano DJ, Reid CM, Jepson C, Feldman HI, Herman WH, et al. Risk of progression of Nonalbuminuric CKD to end-stage Kidney Disease in people with Diabetes: the CRIC (chronic renal insufficiency cohort) study. Am J Kidney Dis. 2018;72(5):653–61.

    Article  PubMed  Google Scholar 

  13. Munakata M, Konno S, Ohshima M, Ikeda T, Miura Y, Ito S. High-normal blood pressure is associated with microalbuminuria in the general population: the Watari study. Hypertens Res. 2011;34(10):1135–40.

    Article  CAS  PubMed  Google Scholar 

  14. Chen F, Yang W, Weng J, Jia W, Ji L, Xiao J, et al. Albuminuria: prevalence, associated risk factors and relationship with Cardiovascular Disease. J Diabetes Investig. 2014;5(4):464–71.

    Article  CAS  PubMed  Google Scholar 

  15. Hao Z, Konta T, Takasaki S, Abiko H, Ishikawa M, Takahashi T, et al. The association between microalbuminuria and metabolic syndrome in the general population in Japan: the Takahata study. Intern Med. 2007;46(7):341–6.

    Article  PubMed  Google Scholar 

  16. Health promotion bureau, Ministry of health, labor and welfare, Japan. Guideline for standard health checkup and health guidance program. In: Supplement 5 Judgment values of health checkup items for recommendations of health consultations or medical examinations. 2018. https://www.mhlw.go.jp/content/10900000/000496784.pdf. Accessed 29 Nov 2023.

  17. Japanese Society of Nephrology. Evidence-based practice guideline for the treatment of CKD. In: Chap. 1: Diagnosis of CKD. 2009. https://jsn.or.jp/en/guideline/pdf/guideline2009.pdf. Accessed 29 Nov 2023.

  18. Ishigami T, Yamamoto R, Nagasawa Y, Isaka Y, Rakugi H, Iseki K, et al. An association between serum γ-glutamyltransferase and proteinuria in drinkers and non-drinkers: a Japanese nationwide cross-sectional survey. Clin Exp Nephrol. 2014;18(6):899–910.

    Article  CAS  PubMed  Google Scholar 

  19. Shen ZW, Xing J, Wang QL, Faheem A, Ji X, Li J, et al. Association between serum γ-glutamyltransferase and chronic Kidney Disease in urban Han Chinese: a prospective cohort study. Int Urol Nephrol. 2017;49(2):303–12.

    Article  CAS  PubMed  Google Scholar 

  20. Ochiai H, Shirasawa T, Yoshimoto T, Nagahama S, Watanabe A, Sakamoto K, et al. Elevated alanine aminotransferase and low aspartate aminotransferase/alanine aminotransferase ratio are associated with chronic Kidney Disease among middle-aged women: a cross-sectional study. BMC Nephrol. 2020;21(1):471.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Liu HW, Liu JS, Kuo KL. Association of nonalcoholic fatty liver and chronic Kidney Disease: an analysis of 37,825 cases from health checkup center in Taiwan. Ci Ji Yi Xue Za Zhi. 2020;32(1):65–9.

    PubMed  Google Scholar 

  22. Nabi O, Boursier J, Lacombe K, Mathurin P, de Ledinghen V, Goldberg M, et al. Comorbidities are Associated with Fibrosis in NAFLD subjects: a Nationwide Study (NASH-CO Study). Dig Dis Sci. 2022;67(6):2584–93.

    Article  PubMed  Google Scholar 

  23. Hwang ST, Cho YK, Yun JW, Park JH, Kim HJ, Park DI, et al. Impact of non-alcoholic fatty Liver Disease on microalbuminuria in patients with prediabetes and Diabetes. Intern Med J. 2010;40(6):437–42.

    Article  CAS  PubMed  Google Scholar 

  24. Shah SV, Baliga R, Rajapurkar M, Fonseca VA. Oxidants in chronic Kidney Disease. J Am Soc Nephrol. 2007;18(1):16–28.

    Article  CAS  PubMed  Google Scholar 

  25. Ravuri C, Svineng G, Pankiv S, Huseby NE. Endogenous production of reactive oxygen species by the NADPH oxidase complexes is a determinant of γ-glutamyltransferase expression. Free Radic Res. 2011;45(5):600–10.

    Article  CAS  PubMed  Google Scholar 

  26. Thamer C, Tschritter O, Haap M, Shirkavand F, Machann J, Fritsche A, et al. Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids. Horm Metab Res. 2005;37(4):246–51.

    Article  CAS  PubMed  Google Scholar 

  27. Xu H, Carrero JJ. Insulin resistance in chronic Kidney Disease. Nephrol (Carlton). 2017;22(Suppl 4):31–4.

    Article  CAS  Google Scholar 

  28. Kasapoglu B, Turkay C, Yalcın KS, Boga S, Bozkurt A. Increased microalbuminuria prevalence among patients with nonalcoholic fatty Liver Disease. Ren Fail. 2016;38(1):15–9.

    Article  CAS  PubMed  Google Scholar 

  29. Chen S, Guo X, Zhang X, Yu S, Yang H, Jiang M, et al. Association between elevated serum alanine aminotransferase and cardiometabolic risk factors in rural Chinese population: a cross-sectional study. BMC Cardiovasc Disord. 2015;15:65.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Choi Y, Park JH, Kim DH, Kim HJ, Suh E, Kim KH, et al. Association between cotinine-verified Smoking status and moderately increased albuminuria in the middle-aged and older population in Korea: a nationwide population-based study. PLoS ONE. 2021;16(2):e0246017.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Ministry of Health, Labour and Welfare. About state of implementation of specific health checkups and specific health guidance scheme. 2023. https://www.mhlw.go.jp/stf/newpage_03092.html. Accessed 29 Nov 2023. (In Japanese).

Download references

Acknowledgements

We wish to express our thanks to Mrs. Shinobu Isomoto (Department of Public Health, Faculty of Medicine, Tokushima University) for her help in this study.

Funding

This study was supported by a grant from Tokushima Prefectural Office. The findings and conclusions of this article are solely the responsibility of the authors and do not represent official views of the government.

Author information

Authors and Affiliations

  1. Department of Public Health, Graduate School of Biomedical Sciences, Tokushima University, 3-18-15, Kuramoto, Tokushima city, Tokushima, 770-8503, Japan

    Shoichi Fukuda, Ukyo Shirase, Mai Nakagawa, Kazumi Nakagawa, Ayumu Tominaga & Hisayoshi Morioka

  2. Mima Public Health Centre, 23-23, Myouren, Anabuki, Mima city, Tokushima, 777-0005, Japan

    Shigeru Ogimoto

Authors
  1. Shoichi Fukuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ukyo Shirase
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shigeru Ogimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mai Nakagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kazumi Nakagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ayumu Tominaga
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hisayoshi Morioka
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

S.O. and H.M. conceptualized and designed the study. S.F. and H.M. analyzed the data. S.F., U.S., M.N., K.N., A.T. and H.M. interpreted the data. S.F., K.N. and H.M. conceptualized the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Hisayoshi Morioka.

Ethics declarations

Ethics approval and consent to participate

Informed consent was obtained from each participant. This study protocol was approved by the Ethics Committee of Tokushima University Hospital (approval number: 3944).

Consent for publication

Not applicable.

Competing interests

All authors declare no conflict of interests associated with this study.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fukuda, S., Shirase, U., Ogimoto, S. et al. Association between elevated serum transaminase and moderately increased albuminuria: a cross-sectional study in western Tokushima, Japan. BMC Nephrol 24, 358 (2023). https://doi.org/10.1186/s12882-023-03411-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12882-023-03411-y

Keywords

BMC Nephrology

ISSN: 1471-2369

Contact us